Table 3. Univariate analysis of survival in patients with GC.
Variable | Mean survival time month (±SE) | 95% CI (Month) | P |
---|---|---|---|
Age (years) | 0.132 | ||
<60 | 57.3(4.8) | 47.9-66.6 | |
≥60 | 48.9(3.4) | 42.3-55.5 | |
Gender | 0.668 | ||
Male | 52.5(3.3) | 46.0-59.0 | |
Female | 50.5(5.1) | 40.6-60.4 | |
Tumour site | 0.986 | ||
Gastric cardia | 53.0(7.4) | 38.5-67.4 | |
Non-cardia | 51.8(3.0) | 45.9-57.7 | |
Stage of disease | 0.000 | ||
I–II | 70.0(4.0) | 62.2-77.8 | |
III–IV | 39.4(3.4) | 32.8-46.1 | |
Tumour status (p) | 0.008 | ||
T1−T2 | 67.5(5.6) | 56.5-78.4 | |
T3−T4 | 48.5(3.0) | 42.6-54.4 | |
Node status | 0.000 | ||
Negative | 72.9(4.8) | 63.6-82.3 | |
Positive | 44.8(3.1) | 38.7-51.0 | |
Distant metastasis | 0.005 | ||
No | 54.0(2.9) | 48.2-59.7 | |
Yes | 30.2(6.4) | 17.6-42.8 | |
FGF9 | 0.000 | ||
High expression | 28.1(3.5) | 21.2-35.0 | |
Low/unchanged | 55.8(3.5) | 48.9-62.7 | |
Tumour size (cm) | |||
≥10 | 28.4(5.0) | 18.5-38.2 | 0.001 |
<10 | 54.8(3.1) | 48.8-60.8 |